Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Competing practice guidelines: using cost-effectiveness analysis to make optimal decisions

A V Granata1, A L Hillman

  • 1Yale School of Medicine, New Haven, Connecticut, USA.

Annals of Internal Medicine
|January 10, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

700,000 years of tropical Andean glaciation.

Nature·2022
Same author

Financial incentives and drug spending in managed care.

LDI issue brief·2003
Same author

Creating illegal immigrants.

Journal of population economics·2002
Same author

HMO behavior and stock market valuation: what does Wall Street reward and punish?

Journal of health care finance·2001
Same author

The future catches up: a medical school curriculum in health economics.

The American journal of the medical sciences·2000
Same author

Financial incentives and drug spending in managed care.

Health affairs (Project Hope)·1999
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Selecting clinical guidelines for individual patients may not maximize population benefit. Resource allocation requires considering both individual and societal health outcomes for efficient healthcare delivery.

Area of Science:

  • Health economics
  • Clinical decision analysis
  • Public health policy

Background:

  • Clinical practice guidelines aim to optimize patient care but may differ in their cost-effectiveness for individuals versus populations.
  • Healthcare resource allocation necessitates balancing individual patient needs with broader societal benefits.

Purpose of the Study:

  • To compare the cost-effectiveness of clinical guidelines selected for maximizing individual patient benefit versus those selected for maximizing overall population benefit.
  • To evaluate how guideline selection impacts population health outcomes under varying cost constraints.

Main Methods:

  • A hypothetical population of 100,000 patients was modeled.
  • Cost and effectiveness data (added survival) from six clinical interventions (prevention, screening, diagnostic, therapeutic) were integrated.

Related Experiment Videos

  • A computer-based optimization model identified guideline clusters maximizing population effectiveness within specified cost constraints.

    • Main Results:

    • Guideline clusters maximizing population benefit differed from those maximizing individual benefit in 57% of selection opportunities.
    • The stability of guideline choices varied across different cost constraint ranges.
    • Individual-focused cost-effectiveness did not consistently translate to population-level cost-effectiveness.

    Conclusions:

    • Clinical practice guidelines optimized for individual patients may not yield the greatest overall population benefit.
    • Efficient resource allocation requires considering information beyond individual guideline recommendations.
    • Development of "robust" guidelines addressing both individual and societal health benefits is recommended.